• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血液透析过程中的细胞因子产生:透析膜和补体激活的影响

Cytokine production during hemodialysis: effects of dialytic membrane and complement activation.

作者信息

Lin Y F, Chang D M, Shaio M F, Lu K C, Chyr S H, Li B L, Sheih S D

机构信息

Division of Nephrology, Tri-Service General Hospital, Taipei, Taiwan.

出版信息

Am J Nephrol. 1996;16(4):293-9. doi: 10.1159/000169012.

DOI:10.1159/000169012
PMID:8739281
Abstract

Interleukin-1 beta (IL-1 beta) and tumor necrosis factor-alpha (TNF-alpha) are closely associated with acute and chronic inflammatory processes in hemodialytic patients. However, the mechanisms concerning cytokine production by monocytes during hemodialysis are still conflicting. With the use of the more specific monoclonal antibody ELISA method, contamination detection and crossover protocol of complement-activating and noncomplement-activating hollow fibers, we were able to confirm augmented II-1 beta production by zymosan-stimulated monocytes with complement-activating hollow fiber as compared to noncomplement-activating hollow fiber before (1,411.9 +/- 865.7 +/- 149.9 pg/ ml/2 x 10(6) monocytes, p < 0.01). at the 15th minute (530.6 +/- 89.1 vs. 247.3 +/- 45.2 pg/ml/2 x 10(6) monocytes, p < 0.01) and at the end of dialysis (1,201.8 +/- 135.1 vs. 707.4 +/- 109.3 pg/ml/2 x 10(6) monocytes, p < 0.01). Similar results were observed with TNF-alpha production. IL-1 beta as well as TNF-alpha production decreased significantly at the 15th min of dialysis, thereafter they increased and approached the baseline levels towards the end of hemodialysis with both hollow fibers. Plasma C3a at the 15th minute correlated positively with postdialysis IL-1 beta and TNF-alpha production, while plasma C3a did not change in patients dialyzed with noncomplement-activating hollow fiber. Complement activation with complement-activating hollow fiber as well as monocyte-membrane interaction with complement-activating and noncomplement-activating hollow fiber might be involved in the pathogenesis of cytokine production during hemodialysis. Uremic toxin removal as well as stimulation of cytokine production inhibitor might contribute to the decreased cytokine production at the 15th minute of hemodialysis and monocyte-membrane interaction with or without complement activation resulted in augmented cytokine production toward the end of hemodialysis with both hollow fibers. We thus concluded that hollow fiber of bioincompatibility triggered much more cytokine production throughout the dialysis procedure.

摘要

白细胞介素-1β(IL-1β)和肿瘤坏死因子-α(TNF-α)与血液透析患者的急慢性炎症过程密切相关。然而,关于血液透析过程中单核细胞产生细胞因子的机制仍存在争议。通过使用更特异的单克隆抗体ELISA方法、补体激活和非补体激活中空纤维的污染检测及交叉方案,我们得以证实,与非补体激活中空纤维相比,经酵母聚糖刺激的单核细胞在使用补体激活中空纤维时,IL-1β的产生增加(透析前:1,411.9±865.7±149.9 pg/ml/2×10⁶单核细胞,p<0.01),在第15分钟时(530.6±89.1对247.3±45.2 pg/ml/2×10⁶单核细胞,p<0.01)以及透析结束时(1,201.8±135.1对707.4±109.3 pg/ml/2×10⁶单核细胞,p<0.01)。TNF-α的产生也观察到类似结果。IL-1β以及TNF-α的产生在透析第15分钟时显著下降,此后它们增加,并在透析结束时接近基线水平,两种中空纤维均如此。第15分钟时的血浆C3a与透析后IL-1β和TNF-α的产生呈正相关,而使用非补体激活中空纤维透析的患者血浆C3a无变化。补体激活中空纤维的补体激活以及补体激活和非补体激活中空纤维与单核细胞膜的相互作用可能参与了血液透析过程中细胞因子产生的发病机制。尿毒症毒素的清除以及细胞因子产生抑制剂的刺激可能导致透析第15分钟时细胞因子产生减少,而单核细胞膜与补体激活或未激活的相互作用导致两种中空纤维在透析结束时细胞因子产生增加。因此,我们得出结论,生物不相容性中空纤维在整个透析过程中引发了更多的细胞因子产生。

相似文献

1
Cytokine production during hemodialysis: effects of dialytic membrane and complement activation.血液透析过程中的细胞因子产生:透析膜和补体激活的影响
Am J Nephrol. 1996;16(4):293-9. doi: 10.1159/000169012.
2
Complement activation in dialysis: effects on cytokines, lymphocyte activation and beta 2 microglobulin.透析中的补体激活:对细胞因子、淋巴细胞活化及β2微球蛋白的影响
Int J Artif Organs. 1994 Jun;17(6):337-44.
3
Intradialytic granulocyte reactive oxygen species production: a prospective, crossover trial.透析期间粒细胞活性氧生成:一项前瞻性交叉试验。
J Am Soc Nephrol. 1993 Aug;4(2):178-86. doi: 10.1681/ASN.V42178.
4
Production of cytokines in hemodialysis.血液透析中细胞因子的产生。
Blood Purif. 1990;8(6):337-46. doi: 10.1159/000169988.
5
Endotoxins modulate chronically tumour necrosis factor alpha and interleukin 6 release by uraemic monocytes.内毒素可长期调节尿毒症单核细胞释放肿瘤坏死因子α和白细胞介素6。
Nephrol Dial Transplant. 1995;10(3):328-33.
6
The influence of dialyzer geometry on blood coagulation and biocompatibility.透析器几何形状对血液凝固和生物相容性的影响。
Clin Nephrol. 1993 Nov;40(5):281-5.
7
Anaphylatoxin formation during hemodialysis: effects of different dialyzer membranes.血液透析过程中的过敏毒素形成:不同透析器膜的影响
Kidney Int. 1983 Dec;24(6):764-9. doi: 10.1038/ki.1983.225.
8
Influence of uremia and hemodialysis on circulating interleukin-1 and tumor necrosis factor alpha.尿毒症和血液透析对循环白细胞介素-1及肿瘤坏死因子α的影响。
Kidney Int. 1990 Jan;37(1):116-25. doi: 10.1038/ki.1990.16.
9
Different complement and granulocyte activation in patients dialyzed with PMMA dialyzers.使用聚甲基丙烯酸甲酯透析器进行透析的患者中补体和粒细胞的不同激活情况。
Clin Nephrol. 1986 Jun;25(6):304-7.
10
Cytokine profiles during clinical high-flux dialysis: no evidence for cytokine generation by circulating monocytes.临床高通量透析期间的细胞因子谱:循环单核细胞未产生细胞因子的证据
J Am Soc Nephrol. 1997 Nov;8(11):1745-54. doi: 10.1681/ASN.V8111745.

引用本文的文献

1
Endothelial Damage, Inflammation and Immunity in Chronic Kidney Disease.慢性肾脏病中的内皮损伤、炎症与免疫
Toxins (Basel). 2020 Jun 1;12(6):361. doi: 10.3390/toxins12060361.
2
Monocytes in Uremia.尿毒症中的单核细胞。
Toxins (Basel). 2020 May 21;12(5):340. doi: 10.3390/toxins12050340.
3
The Complement System in Dialysis: A Forgotten Story?补体系统在透析中的作用:被遗忘的故事?
Front Immunol. 2018 Jan 25;9:71. doi: 10.3389/fimmu.2018.00071. eCollection 2018.
4
AP-VAS 2012 case report: two patients with rheumatoid arthritis suspected of relapsed microscopic polyangiitis after initiation of dialysis.AP-VAS 2012病例报告:两名类风湿关节炎患者在开始透析后疑似复发性显微镜下多血管炎。
CEN Case Rep. 2013 Nov;2(2):170-173. doi: 10.1007/s13730-013-0081-2. Epub 2013 Jul 4.
5
High-flux versus low-flux membranes for end-stage kidney disease.用于终末期肾病的高通量膜与低通量膜
Cochrane Database Syst Rev. 2012 Sep 12;2012(9):CD005016. doi: 10.1002/14651858.CD005016.pub2.
6
Use of drug-eluting stents in patients with coronary artery disease and renal insufficiency.药物洗脱支架在伴有肾功能不全的冠状动脉疾病患者中的应用。
Mayo Clin Proc. 2010 Feb;85(2):165-71. doi: 10.4065/mcp.2009.0314.